AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was $14.58B, up 22.9% from the year before. Over ten years it grew 15.9% a year on average. The highest annual figure on record is $14.58B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.58B | +22.9% |
| FY2024 | Dec 31, 2024 | $11.86B | +14.7% |
| FY2023 | Dec 31, 2023 | $10.35B | +5.5% |
| FY2022 | Dec 31, 2022 | $9.81B | +64.5% |
| FY2021 | Dec 31, 2021 | $5.96B | +24.3% |
| FY2020 | Dec 31, 2020 | $4.80B | +61.6% |
| FY2019 | Dec 31, 2019 | $2.97B | +13.4% |
| FY2018 | Dec 31, 2018 | $2.62B | -26.8% |
| FY2017 | Dec 31, 2017 | $3.58B | -13.7% |
| FY2016 | Dec 31, 2016 | $4.15B | +24.7% |
| FY2015 | Dec 31, 2015 | $3.32B | – |
See a number that looks wrong?